Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nontraditional beta-lactam antibiotics].

H Vanderhaeghe1

  • 1Rega instituut Katholieke Universiteit Leuven.

Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation and properties of the components of staphylomycin.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Microbiologic study of the components of staphylomycin.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Replacement of microbiological assays of antibiotics based on high-performance liquid chromatography.

Journal of pharmaceutical and biomedical analysis·1989
Same author

Quantitative analysis of chlortetracycline and related substances by high-performance liquid chromatography.

Journal of pharmaceutical and biomedical analysis·1989
Same author

A collaborative study of the analysis of doxycycline hyclate by high-performance liquid chromatography on polystyrene-divinylbenzene packing materials.

Journal of pharmaceutical and biomedical analysis·1989
Same author

Tissue distribution and excretion of radioactively labelled compounds in the Wistar rat after administration of [N-methyl-14C]-erythromycin A.

European journal of drug metabolism and pharmacokinetics·1989
Same journal

Air pollution in Belgium: will we be able to comply with the European standards?

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·2012
Same journal

The influence of air pollution on health: mechanistic implications.

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·2012
Same journal

Air pollution and health--air quality standards.

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·2012
Same journal

[Worry about talent in first line health care].

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·2012
Same journal

[Piet de Somer, the University of Leuven and the Belgium poliovaccine in 1956-57].

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·2012
Same journal

[Emergency guidelines for cosmetic procedures and esthetic skin treatment: recommendations of the medical establishment].

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·2012
See all related articles

Novel beta-lactam antibiotics, including clavulanic acid, carbapenems like imipenem, and monobactams such as aztreonam, offer new treatments for bacterial infections. These derivatives expand therapeutic options beyond traditional penicillins and cephalosporins.

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Pharmacology

Context:

  • Traditional beta-lactam antibiotics (penicillins, cephalosporins) face resistance due to bacterial enzymes.
  • Emerging beta-lactam derivatives exhibit unique structures and mechanisms of action.
  • Clinical introduction of novel beta-lactams necessitates understanding their properties and applications.

Purpose:

  • To review recent advancements in beta-lactam antibiotic derivatives.
  • To highlight key structural modifications and their impact on activity.
  • To discuss the therapeutic potential of new beta-lactam agents.

Summary:

  • Beta-lactamase inhibitors like clavulanic acid, sulbactam, and tazobactam are combined with penicillins to overcome resistance.
  • Carbapenems, such as imipenem (derived from thienamycin), provide broad-spectrum activity against Gram-positive and Gram-negative bacteria.

Related Experiment Videos

  • Monobactams, exemplified by aztreonam, offer targeted efficacy against Gram-negative pathogens and are synthesized via total synthesis.

    • Impact:

    • These novel beta-lactams broaden the arsenal against antibiotic-resistant bacteria.
    • Development of synthetic routes enables large-scale production and further research.
    • Expanded treatment options improve patient outcomes for various bacterial infections.